Alexis Borisy

Alexis Borisy
Name	Alexis Borisy

Alexis Borisy is a biotechnology entrepreneur, investor, and executive known for founding and leading companies that translate academic science into therapeutic products. He has been involved with multiple biotechnology startups, venture capital initiatives, and translational research efforts linking academic laboratories with private capital. Borisy's career spans interactions with leading universities, research institutions, pharmaceutical companies, and investment firms across the biotechnology ecosystem.

Early life and education

Borisy was educated in environments connected to prominent research institutions and biotechnology hubs associated with Harvard University, Massachusetts Institute of Technology, Stanford University, and industry clusters such as Cambridge, Massachusetts and Silicon Valley. His formative years included exposure to scientific networks centered on institutions like the Broad Institute, Whitehead Institute, Dana–Farber Cancer Institute, and Beth Israel Deaconess Medical Center. Borisy's academic background connected him with researchers from programs at Johns Hopkins University, University of California, San Francisco, Yale University, and Columbia University, positioning him for roles that bridged laboratory discovery and commercial development.

Career

Borisy's career includes founding and managing biotechnology companies, developing venture capital relationships, and participating in translational initiatives associated with entities such as Flagship Pioneering, Third Rock Ventures, Atlas Venture, and MPM Capital. He has served in executive roles that interfaced with corporate partners including Pfizer, Novartis, Roche, and GlaxoSmithKline, as well as collaborations with nonprofit organizations like the Bill & Melinda Gates Foundation and consortia involving the National Institutes of Health and Wellcome Trust. Borisy's leadership placed him at the intersection of startup formation, intellectual property strategy with offices like the United States Patent and Trademark Office, and alliance management with global pharmaceutical firms and academic technology transfer offices such as those at Stanford University and University of Cambridge.

Research and contributions

Borisy has contributed to translating discoveries from laboratories associated with principal investigators who trained in programs at Massachusetts General Hospital, Cold Spring Harbor Laboratory, Scripps Research, Max Planck Society institutes, and research groups from University of Chicago and Princeton University. His work emphasized pipeline creation, target validation, and preclinical development aligned with regulatory frameworks from the Food and Drug Administration and clinical trial networks including collaborations with National Cancer Institute investigators and academic medical centers like UCLA Health and Mount Sinai Health System. Borisy's contributions include structuring multidisciplinary teams that brought together expertise from structural biology labs, medicinal chemistry groups at Merck Research Laboratories, translational pharmacology units, and clinical development teams associated with academic hospitals and contract research organizations such as IQVIA. These efforts fostered candidate drugs advancing into investigational new drug applications and Phase I/II studies overseen by institutional review boards at centers like Massachusetts General Hospital.

Biotech entrepreneurship and investments

As an entrepreneur and investor, Borisy has been associated with launching companies that attracted financing from venture capital firms including Sequoia Capital, Benchmark Capital, New Enterprise Associates, and corporate venture arms of companies like Johnson & Johnson Innovation and Takeda Ventures. He has worked on seed and series funding rounds involving investors such as Andreessen Horowitz, ARCH Venture Partners, and philanthropic backers like Wellcome Trust and the Gates Foundation. Borisy's portfolio includes ventures that partnered with contract manufacturing organizations, entered collaborations with biotech accelerators, and utilized incubator spaces adjoining institutions such as MIT Kendall Square and Harvard Innovation Labs. His investment and operational activities intersected with licensing agreements negotiated with university technology transfer offices and strategic alliances with multinational pharmaceutical companies for co-development and commercialization.

Awards and honors

Borisy's professional recognition includes mentions and affiliations with award-granting organizations and industry groups such as the Biotechnology Innovation Organization, MassBio, and venture awards presented by outlets like BioCentury and FierceBiotech. He has been featured in industry lists and conference programs at gatherings hosted by JP Morgan Healthcare Conference, BIO International Convention, and forums organized by TEDMED and Nature Biotechnology. Institutional acknowledgments include invitations to advisory roles at research institutes and participation on scientific advisory boards connected to universities and translational research centers.

Personal life

Borisy's personal affiliations include participation in professional networks linking entrepreneurs, academics, and investors across hubs such as Boston, Massachusetts, Cambridge, United Kingdom, and San Francisco Bay Area. He has engaged with philanthropy and nonprofit initiatives collaborating with organizations like The Rockefeller Foundation and community science outreach programs that partner with museums and public institutions. Borisy maintains professional memberships consistent with roles in startup governance, board service, and advisory capacities across academic and industry organizations.

Category:Biotechnology entrepreneurs